Filing Details

Accession Number:
0000950170-23-052700
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-10-10 17:26:29
Reporting Period:
2023-10-06
Accepted Time:
2023-10-10 17:26:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1088856 Corcept Therapeutics Inc CORT Pharmaceutical Preparations (2834) 770487658
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1817838 Douglas Joseph Lyon C/O Corcept Therapeutics Incorporated
149 Commonwealth Drive
Menlo Park CA 94025
Chief Accounting Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-10-06 2,582 $11.35 8,436 No 4 M Direct
Common Stock Disposition 2023-10-06 2,582 $27.24 5,854 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock option (right to buy) Disposition 2023-10-06 2,582 $0.00 2,582 $11.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
54,167 2029-02-08 No 4 M Direct
Footnotes
  1. Includes 1,155 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 1,411 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023 and 361 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
  2. The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.
  3. Fully exercisable.